192 Publications (Page 7 of 8)
2007
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugsVerheul, Henk M⋅Verheul, Henk⋅Qian, David⋅Qian, David⋅Carducci, Michael A⋅Carducci, Michael⋅Pili, Roberto and Pili, RobertoCancer Chemotherapy and Pharmacology, vol. 60, (no. 3), pp. 339, 20070800.
| Journal Article
Synergistic In vivo Antitumor Effect of the Histone Deacetylase Inhibitor MS-275 in Combination with Interleukin 2 in a Murine Model of Renal Cell CarcinomaKato, Yukihiko⋅Yoshimura, Kiyoshi⋅Shin, Tahiro⋅Verheul, Henk⋅Hammers, Hans⋅Sanni, Tolib⋅Salumbides, Brenda⋅Erp, Karen⋅Schulick, Richard and Pili, RobertoClinical Cancer Research, vol. 13, (no. 15), pp. 4546, 20070801.
| Journal Article
The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved in Vesicular Recycling of E-CadherinKachhap, Sushant K⋅Kachhap, Sushant K⋅Kachhap, Sushant K⋅Faith, Dennis⋅Faith, Dennis⋅Dennis, Faith⋅Qian, David⋅Qian, David Z⋅Qian, David Z⋅Shabbeer, Shabana⋅Shabbeer, Shabana⋅Shabbeer, Shabana⋅Galloway, Nathan L⋅Galloway, Nathan L⋅Galloway, Nathan L⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Denmeade, Samuel R⋅Denmeade, Samuel R⋅Denmeade, Samuel R⋅DeMarzo, Angelo M⋅DeMarzo, Angelo M⋅DeMarzo, Angelo M⋅Carducci, Michael A⋅Carducci, Michael A and Carducci, Michael APloS one, vol. 2, (no. 9), pp. e844, 2007-Sep-05.
| Journal Article
Vascular Endothelial Growth Factor Trap Blocks Tumor Growth, Metastasis Formation, and Vascular Leakage in an Orthotopic Murine Renal Cell Cancer ModelVerheul, Henk⋅Hammers, Hans⋅Erp, Karen⋅Wei, Yonfeng⋅Sanni, Tolib⋅Salumbides, Brenda⋅Qian, David⋅Yancopoulos, George and Pili, RobertoClinical Cancer Research, vol. 13, (no. 14), pp. 4208, 20070715.
| Journal Article
2006
Class II Histone Deacetylases Are Associated with VHL-Independent Regulation of Hypoxia-Inducible Factor 1αQian, David Z⋅Kachhap, Sushant K⋅Collis, Spencer J⋅Verheul, Henk M W⋅Carducci, Michael A⋅Atadja, Peter and Pili, RobertoCancer research, vol. 66, (no. 17), pp. 8821, 2006-Sep-01.
| Journal Article
Identification of ABR‐215050 as lead second generation quinoline‐3‐carboxamide anti‐angiogenic agent for the treatment of prostate cancerIsaacs, John T⋅Pili, Roberto⋅Qian, David Z⋅Dalrymple, Susan L⋅Garrison, Jason B⋅Kyprianou, Natasha⋅Björk, Anders⋅Olsson, Anders and Leanderson, TomasThe Prostate, vol. 66, (no. 16), pp. 1778, 1 December 2006.
| Journal Article
Identification of Type 1 Inosine Monophosphate Dehydrogenase as an Antiangiogenic Drug TargetChong, Curtis R⋅Qian, David Z⋅Pan, Fan⋅Wei, Yongfeng⋅Pili, Roberto⋅Sullivan, David J and Liu, Jun OJournal of Medicinal Chemistry, vol. 49, (no. 9), pp. 2680, 20060504.
| Journal Article
Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced CancerCarducci, Michael⋅Carducci, Michael A⋅Carducci, Michael⋅Musib, Luna⋅Musib, Luna⋅Musib, Luna⋅Kies, Merrill⋅Kies, Merrill⋅Kies, Merrill S⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Truong, Mylene⋅Truong, Mylene⋅Truong, Mylene⋅Brahmer, Julie R⋅Brahmer, Julie⋅Brahmer, Julie⋅Cole, Patricia⋅Cole, Patricia⋅Cole, Patricia⋅Sullivan, Rana⋅Sullivan, Rana⋅Sullivan, Rana⋅Riddle, Jeanne⋅Riddle, Jeanne⋅Riddle, Jeanne⋅Schmidt, Jill⋅Schmidt, Jill⋅Schmidt, Jill⋅Enas, Nathan⋅Enas, Nathan⋅Enas, Nathan⋅Sinha, Vikram⋅Sinha, Vikram⋅Sinha, Vikram⋅Thornton, Donald E⋅Thornton, Donald⋅Thornton, Donald⋅Herbst, Roy⋅Herbst, Roy S and Herbst, RoyJournal of Clinical Oncology, vol. 24, (no. 25), pp. 4099, 20060901.
| Journal Article
Phase II Evaluation of Docetaxel Plus Exisulind in Patients With Androgen Independent Prostate CarcinomaSinibaldi, Victoria J⋅Sinibaldi, Victoria J⋅Elza-Brown, Kathy⋅Elza-Brown, Kathy⋅Schmidt, Jill⋅Schmidt, Jill⋅Eisenberger, Mario A⋅Eisenberger, Mario A⋅Rosenbaum, Eli⋅Rosenbaum, Eli⋅Denmeade, Samuel R⋅Denmeade, Samuel R⋅Pili, Roberto⋅Pili, Roberto⋅Walczak, Janet⋅Walczak, Janet⋅Baker, Sharyn D⋅Baker, Sharyn D⋅Zahurak, Marianna⋅Zahurak, Marianna⋅Carducci, Michael A and Carducci, Michael AAmerican journal of clinical oncology, vol. 29, (no. 4), pp. 398, 2006-Aug.
| Journal Article
Targeting Tumor Angiogenesis with Histone Deacetylase Inhibitors: the Hydroxamic Acid Derivative LBH589Qian, David⋅Qian, David⋅Kato, Yukihiko⋅Kato, Yukihiko⋅Shabbeer, Shabana⋅Shabbeer, Shabana⋅Wei, Yongfeng⋅Wei, Yongfeng⋅Verheul, Hendrik M⋅Verheul, Hendrik⋅Salumbides, Brenda⋅Salumbides, Brenda⋅Sanni, Tolib⋅Sanni, Tolib⋅Atadja, Peter⋅Atadja, Peter⋅Pili, Roberto and Pili, RobertoClinical Cancer Research, vol. 12, (no. 2), pp. 642, 20060115.
| Journal Article
2005
A New High Affinity Technetium-99m-Bombesin Analogue with Low Abdominal AccumulationLin, Kuo-Shyan⋅Lin, K-S⋅Luu, Andrew⋅Luu, A.⋅Baidoo, Kwamena E⋅Baidoo, KE⋅Hashemzadeh-Gargari, H.⋅Hashemzadeh-Gargari, Hossein⋅Chen, M-K⋅Chen, Ming-Kai⋅Brenneman, K.⋅Brenneman, Kenneth⋅Pili, Roberto⋅Pili, Roberto⋅Pomper, Martin G⋅Pomper, Martin⋅Carducci, Michael A⋅Carducci, Michael A⋅Wagner, Henry N and Wagner, HN JBioconjugate Chemistry, vol. 16, (no. 1), pp. 50, 20050119.
| Journal Article
A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.Heath, Elisabeth I⋅Heath, Elisabeth I⋅Gaskins, Melvin⋅Gaskins, Melvin⋅Pitot, Henry C⋅Pitot, Henry C⋅Pili, Roberto⋅Pili, Roberto⋅Tan, Winston⋅Tan, Winston W⋅Marschke, Robert⋅Marschke, Robert⋅Liu, Glenn⋅Liu, Glenn⋅Hillman, David⋅Hillman, David⋅Sarkar, Fazlul⋅Sarkar, Fazlul⋅Sheng, Shijie⋅Sheng, Shijie⋅Erlichman, Charles⋅Erlichman, Charles⋅Ivy, Percy and Ivy, PercyClinical prostate cancer, vol. 4, (no. 2), pp. 138-141, September 2005.
| Journal Article
Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinomaWang, Xiao-Fei⋅Qian, David Z⋅Ren, Mingqiang⋅Kato, Yukihiko⋅Wei, Yongfeng⋅Zhang, Lu⋅Fansler, Zoya⋅Clark, Doug⋅Nakanishi, Osamu and Pili, RobertoClinical cancer research : an official journal of the American Association for Cancer Research, vol. 11, (no. 9), pp. 3535, 2005-May-01.
| Journal Article
Epigenetic Modulation of Retinoic Acid Receptor β2 by the Histone Deacetylase Inhibitor MS-275 in Human Renal Cell CarcinomaWang, Xiao-fei⋅Qian, David⋅Ren, Mingqiang⋅Kato, Yukihiko⋅Wei, Yongfeng⋅Zhang, Lu⋅Fansler, Zoya⋅Clark, Doug⋅Nakanishi, Osamu and Pili, RobertoClinical Cancer Research, vol. 11, (no. 9), pp. 3535, 20050501.
| Journal Article
In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cellsQian, David⋅Qian, David Z⋅Ren, Mingqiang⋅Ren, Mingqiang⋅Wei, Yongfeng⋅Wei, Yongfeng⋅Wang, Xiaofei⋅Wang, Xiaofei⋅van de Geijn, Fleur⋅van de Geijn, Fleur⋅Rasmussen, Camilla⋅Rasmussen, Camilla⋅Nakanishi, Osamu⋅Nakanishi, Osamu⋅Sacchi, Nicoletta⋅Sacchi, Nicoletta⋅Pili, Roberto and Pili, RobertoThe Prostate, vol. 64, (no. 1), pp. 20, 2005-Jun-15.
| Journal Article
In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS‐275 in retinoid‐resistant prostate cancer cellsQian, David Z⋅Ren, Mingqiang⋅Wei, Yongfeng⋅Wang, Xiaofei⋅van de Geijn, Fleur⋅Rasmussen, Camilla⋅Nakanishi, Osamu⋅Sacchi, Nicoletta and Pili, RobertoThe Prostate, vol. 64, (no. 1), pp. 28, 15 June 2005.
| Journal Article
Kidney cancer. Clinical practice guidelinesMotzer, Robert J⋅Motzer, Robert J⋅Carducci, Michael A⋅Carducci, Michael A⋅Fishman, Mayer⋅Fishman, Mayer⋅Hancock, Steven L⋅Hancock, Steven L⋅Hauke, Ralph J⋅Hauke, Ralph J⋅Hudes, Gary R⋅Hudes, Gary R⋅Kantoff, Philip⋅Kantoff, Philip⋅Kuzel, Timothy M⋅Kuzel, Timothy M⋅Lange, Paul H⋅Lange, Paul H⋅Levine, Ellis G⋅Levine, Ellis G⋅Logothetis, Christopher⋅Logothetis, Chris⋅Margolin, Kim A⋅Margolin, Kim⋅Pili, Roberto⋅Pili, Roberto⋅Pohar, Kamal S⋅Pohar, Kamal S⋅Redman, Bruce G⋅Redman, Bruce G⋅Richey, Sylvia⋅Richey, Sylvia⋅Robertson, Cary N⋅Robertson, Cary N⋅Samlowski, Wolfram E⋅Samlowski, Wolfram E⋅Sheinfeld, Joel⋅Sheinfeld, Joel⋅Urban, Donald A and Urban, Donald AJournal of the National Comprehensive Cancer Network : JNCCN, vol. 3, (no. 1), pp. 84, 2005-Jan.
| Journal Article
Marimastat in the Treatment of Patients with Biochemically Relapsed Prostate Cancer: A Prospective Randomized, Double-Blind, Phase I/II TrialRosenbaum, Eli⋅Rosenbaum, Eli⋅Zahurak, Marianna⋅Zahurak, Marianna⋅Sinibaldi, Victoria⋅Sinibaldi, Victoria⋅Carducci, Michael A⋅Carducci, Michael⋅Pili, Roberto⋅Pili, Roberto⋅Laufer, Menachem⋅Laufer, Menachem⋅De Weese, Theodore L⋅DeWeese, Theodore⋅Eisenberger, Mario and Eisenberger, Mario AClinical Cancer Research, vol. 11, (no. 12), pp. 4443, 20050615.
| Journal Article
Modeling the Cost of Management Options for Stage I Nonseminomatous Germ Cell Tumors: A Decision Tree AnalysisLink, Richard E⋅Link, Richard⋅Allaf, Mohamad⋅Allaf, Mohamad E⋅Pili, Roberto⋅Pili, Roberto⋅Kavoussi, Louis R and Kavoussi, LouisJournal of Clinical Oncology, vol. 23, (no. 24), pp. 5773, 20050820.
| Journal Article
2004
A New High Affinity Technetium Analogue of Bombesin Containing DTPA as a Pharmacokinetic ModifierLin, Kuo-Shyan⋅Luu, Andrew⋅Baidoo, Kwamena E⋅Hashemzadeh-Gargari, Hossein⋅Chen, Ming-Kai⋅Pili, Roberto⋅Pomper, Martin⋅Carducci, Michael and Wagner, Henry NBioconjugate Chemistry, vol. 15, (no. 6), pp. 1423, 20041117.
| Journal Article
A Phase II Trial of Temozolomide and IFN-α in Patients with Advanced Renal Cell CarcinomaSunkara, Usha⋅Sunkara, Usha⋅Walczak, Janet R⋅Walczak, Janet R⋅Summerson, Lori⋅Summerson, Lori⋅Rogers, Theresa⋅Rogers, Theresa⋅Eisenberger, Mario⋅Eisenberger, Mario A⋅Denmeade, Samuel⋅Denmeade, Samuel R⋅Pili, Roberto⋅Pili, Roberto⋅Huff, Carol A⋅Huff, Carol A⋅Sinibaldi, Victoria⋅Sinibaldi, Victoria⋅Carducci, Michael A and Carducci, Michael AJournal of Interferon & Cytokine Research, vol. 24, (no. 1), pp. 37-41, Jan 2004.
| Journal Article
Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous LeukemiasKarp, Judith⋅Gojo, Ivana⋅Pili, Roberto⋅Gocke, Christopher⋅Greer, Jacqueline⋅Guo, Chuanfa⋅Qian, David⋅Morris, Lawrence⋅Tidwell, Michael⋅Chen, Helen and Zwiebel, JamesClinical Cancer Research, vol. 10, (no. 11), pp. 3577, 20040601.
| Journal Article
Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumabKarp, Judith E⋅Karp, Judith E⋅Gojo, Ivana⋅Gojo, Ivana⋅Pili, Roberto⋅Pili, Roberto⋅Gocke, Christopher D⋅Gocke, Christopher D⋅Greer, Jacqueline⋅Greer, Jacqueline⋅Guo, Chuanfa⋅Guo, Chuanfa⋅Qian, David⋅Qian, David⋅Morris, Lawrence⋅Morris, Lawrence⋅Tidwell, Michael⋅Tidwell, Michael⋅Chen, Helen⋅Chen, Helen⋅Zwiebel, James and Zwiebel, JamesClinical cancer research : an official journal of the American Association for Cancer Research, vol. 10, (no. 11), pp. 3577, 2004-Jun-01.
| Journal Article
The Histone Deacetylase Inhibitor NVP-LAQ824 Inhibits Angiogenesis and Has a Greater Antitumor Effect in Combination with the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor PTK787/ZK222584Qian, David⋅Qian, David⋅Wang, Xiaofei⋅Wang, Xiaofei⋅Kachhap, Sushant K⋅Kachhap, Sushant⋅Kato, Yukihiko⋅Kato, Yukihiko⋅Wei, Yongfeng⋅Wei, Yongfeng⋅Zhang, Lu⋅Zhang, Lu⋅Atadja, Peter⋅Atadja, Peter⋅Pili, Roberto and Pili, RobertoCancer Research, vol. 64, (no. 18), pp. 6634, 20040915.
| Journal Article
2003
CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical ModelsRuggeri, Bruce⋅Ruggeri, Bruce⋅Singh, Jasbir⋅Singh, Jasbir⋅Gingrich, Diane⋅Gingrich, Diane⋅Angeles, Thelma⋅Angeles, Thelma⋅Albom, Mark⋅Albom, Mark⋅Chang, Hong⋅Yang, Shi⋅Chang, Hong⋅Robinson, Candy⋅Robinson, Candy⋅Hunter, Kathryn⋅Hunter, Kathryn⋅Dobrzanski, Pawel⋅Dobrzanski, Pawel⋅Jones-Bolin, Susan⋅Jones-Bolin, Susan⋅Aimone, Lisa⋅Aimone, Lisa⋅Klein-Szanto, Andres⋅Pritchard, Sonya⋅Klein-Szanto, Andres⋅Herbert, Jean-Marc⋅Herbert, Jean-Marc⋅Bono, Francoise⋅Bono, Francoise⋅Schaeffer, Paul⋅Schaeffer, Paul⋅Casellas, Pierre⋅Casellas, Pierre⋅Bourie, Bernard⋅Bourie, Bernard⋅Pili, Roberto⋅Pili, Roberto⋅Isaacs, John T⋅Isaacs, John⋅Ator, Mark⋅Ator, Mark⋅Hudkins, Robert⋅Hudkins, Robert⋅Vaught, Jeffry⋅Mallamo, John⋅Mallamo, John⋅Dionne, Craig⋅Dionne, Craig and Vaught, JeffreyCancer Research, vol. 63, (no. 18), pp. 5978, 20030915.
| Journal Article